ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,102Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 151

$353K Total Retail Price of All Prescriptions

Rank: 81 out of 151

594 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 594 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 594 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 9,562 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 796 754 1 1
ENALAPRIL MALEATE 598 557 2 38
LEVOTHYROXINE SODIUM 443 433 3 2
ATENOLOL 404 390 4 11
AMLODIPINE BESYLATE 280 262 5 3
TEMAZEPAM 269 268 6 49
DOXAZOSIN MESYLATE 264 251 7 77
METOPROLOL TARTRATE 258 249 8 7
LOVASTATIN 220 211 9 31
FUROSEMIDE 219 214 10 6
ALPRAZOLAM 200 194 11 41
ALENDRONATE SODIUM 197 193 12 26
WARFARIN SODIUM 190 187 13 9
CAPTOPRIL 170 170 14 183
METFORMIN HCL 169 163 15 8
HYDROCODONE-ACETAMINOPHEN 148 113 S3 16 10
CLONIDINE HCL 144 138 17 52
GLYBURIDE 138 131 R 18 75
GLIMEPIRIDE 135 128 19 58
LISINOPRIL 132 117 20 5
TRIAMTERENE-HCTZ 130 128 21 68
ALLOPURINOL 128 116 22 42
LOSARTAN POTASSIUM 117 100 23 12
CEPHALEXIN 115 109 24 108
METOPROLOL SUCCINATE 113 109 25 21
NIFEDIPINE ER 106 105 26 83
FELODIPINE ER 102 102 27 164
SULFAMETHOXAZOLE-TRIMETHOPRIM 94 93 28 128
PAROXETINE HCL 93 93 29 54
CARVEDILOL 92 89 30 22
PLAVIX 88 87 31 37
HYDROCHLOROTHIAZIDE 88 83 31 13
DIGOXIN 88 85 31 39
DIOVAN 82 82 34 33
VIAGRA 81 81 35 74
AZITHROMYCIN 68 64 36 36
POTASSIUM CHLORIDE 68 68 36 19
OMEPRAZOLE 68 65 36 4
ZETIA 67 54 39 131
LORAZEPAM 66 66 40 94
CLOPIDOGREL 64 61 41 29
DONEPEZIL HCL 63 63 42 15
TRAMADOL HCL 61 59 43 24
ZOLPIDEM TARTRATE 58 58 44 17
NIFEDICAL XL 56 50 45 332
VERAPAMIL ER 56 48 45 112
GABAPENTIN 54 48 47 14
INSULIN SYRINGE 54 47 47 96
MELOXICAM 53 52 49 57
PROAIR HFA 53 49 49 71
MECLIZINE HCL 52 51 51 86
METHYLPREDNISOLONE 52 51 51 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 21, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.